We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fast Acting Cyanide Antidote Discovered

By HospiMedica staff writers
Posted on 07 Jan 2008
A new, fast-acting antidote to cyanide poisoning has the potential to save the lives of those who are exposed to the chemical, including firefighters, industrial workers, and victims of terrorist attack.

Researchers of the University of Minnesota (Minneapolis, USA) Center for Drug Design and the Minneapolis Veterans Affairs (VA) Medical Center (MN, USA) developed the antidote based on mechanisms used by the body to detoxify small amounts of cyanide that occur naturally in pitted fruits, some grasses, and other foods. More...
The new antidote takes advantage of this natural detoxification pathway by providing the substance the body uses to convert cyanide to non-toxic thiocyanate. The antidote was tested on animal models, and human clinical trials are expected to begin during the next three years. The antidote, which works in less than three minutes, can be taken orally (current antidotes must be given intravenously) and may be administered up to an hour prior to cyanide exposure. The antidote was discovered by retired University of Minnesota professor Herbert Nagasawa, Ph.D. The study was published in the December 27, 2007, issue of the Journal of Medicinal Chemistry.

"It's much, much faster than current antidotes,” said lead author Steven Patterson, Ph.D., associate director of the University of the Minnesota Center for Drug Design. "The antidote is also effective over a wider time window. Giving emergency responders more time is important because it's not likely that someone will be exposed to cyanide near a paramedic.”

Cyanide is a rapid acting toxin that inhibits cellular respiration, rapidly shutting down many of the fundamental biochemical processes the body needs to survive. Symptoms of acute cyanide poisoning include headache, vertigo, lack of motor coordination, weak pulse, abnormal heartbeat, vomiting, stupor, convulsions, coma, and even death. When released in an enclosed area, cyanide can be particularly deadly and impact a victim very quickly. Survivors of cyanide poisoning are also at risk of short-term memory loss and development of a Parkinson's-like syndrome.


Related Links:
University of Minnesota
Minneapolis VA medical center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.